Clinical analysis of permanent, biodegradable and polymer-free drug eluting stent in treatment of unprotected left main coronary artery disease

Clinical analysis of permanent, biodegradable and polymer-free drug eluting stent in treatment of unprotected left main coronary artery disease

Objective To compare the safety and efficacy of 3 kinds of permanent, biodegradable and polymer free drug eluting stents in the treatment of unprotected left main coronary artery disease (UPLM). Methods A total of 259 UPLM patients diagnosed by coronary angiography and underwent percutaneous coronar...

Full description

Bibliographic Details
Main Authors:	ZHOU Denglu, CHEN Jianfei, SONG Mingbao, JIN Jun, SONG Yaoming
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Third Military Medical University 2019-03-01
Series:	Di-san junyi daxue xuebao
Subjects:	coronary atherosclerotic heart disease unprotected left main coronary artery drug-eluting stent permanent polymer drug eluting stent biodegradable polymer free
Online Access:	http://aammt.tmmu.edu.cn/Upload/rhtml/201811103.htm

Similar Items

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
by: Rainer Zbinden, et al.
Published: (2016-03-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
by: Walid Maamoun
Published: (2013-09-01)

Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience.
by: Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France), et al.
Published: (2021-01-01)

Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern India
by: Shuvanan Ray, et al.
Published: (2016-01-01)

Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis
by: Hong Wang, et al.
Published: (2023-08-01)

Very Long-term Outcomes and Predictors of Percutaneous Coronary Intervention with Drug-eluting Stents Versus Coronary Artery Bypass Grafting for Patients with Unprotected Left Main Coronary Artery Disease
by: Xian-Peng Yu, et al.
Published: (2016-01-01)

Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents
by: Raghava Sarma Polavarapu, et al.
Published: (2023-07-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
by: Xiao-Fang Tang, et al.
Published: (2018-08-01)

Coronary artery aneurysms following drug eluting stents implantation: A retrospective analysis from series of cases at tertiary care cardiac centre over three years
by: Sudarshan Kumar Vijay, et al.
Published: (2019-01-01)

Triple-vessel coronary artery aneurysms following drug-eluting stents
by: Immaneni Sathyamurthy, et al.
Published: (2023-01-01)

Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry
by: Robert J. Gil, et al.
Published: (2020-02-01)

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus
by: Tobias Lenz, et al.
Published: (2021-06-01)

Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model
by: Takeshi Ijichi, et al.
Published: (2021-06-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: a meta-analysis of randomized control trials
by: Kang Gao, et al.
Published: (2017-07-01)

Sirolimus Release from Biodegradable Polymers for Coronary Stent Application: A Review
by: Wei Xu, et al.
Published: (2022-02-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Clinical Outcomes of Biodegradable versus Durable Polymer Drug Eluting Stents in Rotational Atherectomy: Results from ROCK Registry
by: Kyung An Kim, et al.
Published: (2022-10-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation
by: Pritam Patil, et al.
Published: (2014-03-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

POR QUÉ USAR PREFERENTEMENTE STENTS NO FARMACOACTIVOS / Why it is preferable to use non-drug-eluting stents
by: Rosa Lázaro García, et al.
Published: (2013-10-01)

Clinical follow-up of long nontapered sirolimus-eluting coronary stent in real-world patients with de novo lesions. The Billar registry
by: Enric Domingo Ribas, et al.
Published: (2022-02-01)

Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study
by: Tharusha D. Gunawardena, et al.
Published: (2023-02-01)

Stent thrombosis: Prevention and management
by: Rajendra Kumar Jain, et al.
Published: (2014-01-01)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
by: Juan F. Iglesias, et al.
Published: (2019-11-01)

Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents
by: Pierre Brami, et al.
Published: (2023-10-01)

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
by: Eline H. Ploumen, et al.
Published: (2022-11-01)

Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
by: Ajmera P, et al.
Published: (2019-10-01)

Comparison of clinical outcomes of patients treated with Cre8TM versus Resolute Onyx™ stent
by: Ahmad Separham, et al.
Published: (2021-06-01)

Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus
by: Alexander Thomas, MD, et al.
Published: (2022-03-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
by: Lulu Liu, et al.
Published: (2018-03-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
by: Paweł Gąsior, et al.
Published: (2018-11-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
by: Xiao-Zeng Wang, et al.
Published: (2015-01-01)